Literature DB >> 23280462

Substance screening and referral for substance abuse treatment in an integrated mental health care program.

Ya-Fen Chan1, Hsiang Huang, Nida Sieu, Jürgen Unützer.   

Abstract

OBJECTIVE: This study examined rates of substance screening and referral for substance abuse treatment as part of an integrated care program providing mental health services to low-income patients in primary care.
METHODS: Adults (N=11,150) who were enrolled in the program between 2008 and 2010 were included. Primary outcomes included substance screening rates, treatment referral rates, and correlates of accessing recommended treatment.
RESULTS: A total of 7,513 (67%) participants were screened for substance abuse. Among the 2,856 (38%) participants with a positive screen, 1,344 (47%) were referred for treatment. After adjustment for covariates, accessing recommended treatment was associated with past substance abuse treatment history, alcohol use, heavy drug use, posttraumatic stress disorder, and number of follow-up contacts with a care manager.
CONCLUSION: This study of a vulnerable population highlights missed opportunities for identifying and referring patients in primary care to substance abuse treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23280462      PMCID: PMC3727141          DOI: 10.1176/appi.ps.201200082

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  13 in total

Review 1.  Psychosocial approaches to dual diagnosis.

Authors:  R E Drake; K T Mueser
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

2.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

3.  Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.

Authors:  Michael L Dennis; Ya-Fen Chan; Rodney R Funk
Journal:  Am J Addict       Date:  2006

4.  Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment.

Authors:  Ya-Fen Chan; Michael L Dennis; Rodney R Funk
Journal:  J Subst Abuse Treat       Date:  2007-06-15

5.  Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

Authors:  Jürgen Unützer; Wayne Katon; Christopher M Callahan; John W Williams; Enid Hunkeler; Linda Harpole; Marc Hoffing; Richard D Della Penna; Polly Hitchcock Noël; Elizabeth H B Lin; Patricia A Areán; Mark T Hegel; Lingqi Tang; Thomas R Belin; Sabine Oishi; Christopher Langston
Journal:  JAMA       Date:  2002-12-11       Impact factor: 56.272

6.  Alcohol screening and brief intervention in primary care settings: implementation models and predictors.

Authors:  Thomas E Babor; John Higgins-Biddle; Deborah Dauser; Pamela Higgins; Joseph A Burleson
Journal:  J Stud Alcohol       Date:  2005-05

7.  Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives.

Authors:  J H Samet; P Friedmann; R Saitz
Journal:  Arch Intern Med       Date:  2001-01-08

8.  Alcohol-related discussions during general medicine appointments of male VA patients who screen positive for at-risk drinking.

Authors:  Katharine A Bradley; Amee J Epler; Kristen R Bush; Jennifer L Sporleder; Christopher W Dunn; Nancy E Cochran; Clarence H Braddock; Mary B McDonell; Stephan D Fihn
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

9.  Variations in depression care and outcomes among high-risk mothers from different racial/ethnic groups.

Authors:  Hsiang Huang; Ya-Fen Chan; Wayne Katon; Karen Tabb; Nida Sieu; Amy M Bauer; Jessica Knaster Wasse; Jürgen Unützer
Journal:  Fam Pract       Date:  2011-11-16       Impact factor: 2.267

10.  Disparities in use of mental health and substance abuse services by persons with co-occurring disorders.

Authors:  Barbara E Havassy; Jennifer Alvidrez; Amy A Mericle
Journal:  Psychiatr Serv       Date:  2009-02       Impact factor: 4.157

View more
  6 in total

Review 1.  Developing a Collaborative Care Training Program in a Psychiatry Residency.

Authors:  Hsiang Huang; Marshall Forstein; Robert Joseph
Journal:  Psychosomatics       Date:  2016-12-20       Impact factor: 2.386

2.  Brief intervention for problem drug use in safety-net primary care settings: a randomized clinical trial.

Authors:  Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin
Journal:  JAMA       Date:  2014-08-06       Impact factor: 56.272

3.  Screening and Follow-Up Monitoring for Substance Use in Primary Care: An Exploration of Rural-Urban Variations.

Authors:  Ya-Fen Chan; Shou-En Lu; Bill Howe; Hendrik Tieben; Theresa Hoeft; Jürgen Unützer
Journal:  J Gen Intern Med       Date:  2015-08-13       Impact factor: 5.128

4.  Referral to Treatment After Positive Screens for Unhealthy Drug Use in an Outpatient Veterans Administration Setting.

Authors:  Dominic Hodgkin; Wenwu Gao; Mary Jo Larson; Charles E Drebing; Elizabeth L Merrick; Marianne Pugatch; Constance M Horgan; Galina Zolotusky; Nancy M Petry; Richard Saitz
Journal:  J Addict Med       Date:  2020 May/Jun       Impact factor: 4.647

5.  Associations of Common Depression Treatment Metrics With Patient-centered Outcomes.

Authors:  Andrew D Carlo; Anirban Basu; Jürgen Unützer
Journal:  Med Care       Date:  2021-07-01       Impact factor: 3.178

6.  Principles of Care for Young Adults With Co-Occurring Psychiatric and Substance Use Disorders.

Authors:  Andrea E Spencer; Sarah E Valentine; Jennifer Sikov; Amy M Yule; Heather Hsu; Eliza Hallett; Ziming Xuan; Michael Silverstein; Lisa Fortuna
Journal:  Pediatrics       Date:  2021-01       Impact factor: 7.124

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.